Announcements Trials

Browse Landscape

Phase

Phase 2 28 Phase 3 5 Phase 1 5 Phase 4 2 Phase NA 1 Phase 2/3 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Carcinoma, Non-Small-Cell Lung 13 Lung Neoplasms 5 Mesothelioma 4 Neoplasms 2 NSCLC 2 Recurrence 1 Nonsquamous Non-small Cell Lung Cancer 1 Non-squamous Non-small Cell Lung Cancer 1 Mesothelioma, Malignant 1 Adenocarcinoma of Lung 1

Interventions

Taxes 1 Specimen Handling 1 Radiotherapy 1 Radiation 1 Pharmacogenomic Testing 1 Pemetrexed 1 Paclitaxel 1 Nivolumab 1 Magnetic Resonance Spectroscopy 1 Ipilimumab 1 Cisplatin 1 Carboplatin 1 CTLA-4 Antigen 1 Biopsy 1 Bevacizumab 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 2/3 × Adenocarcinoma of Lung × Pemetrexed × Clear all

NCT03380468 2023-07-20

ECTOP-1004

Fudan University

Phase 2/3 Unknown

Adenocarcinoma of Lung, Lung Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡